The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Cloning of adiponectin receptors that mediate antidiabetic metabolic effects
Abstract
Adiponectin (also known as 30-kDa adipocyte complement-related protein; Acrp30) is a hormone secreted by adipocytes that acts as an antidiabetic and anti-atherogenic adipokine. Levels of adiponectin in the blood are decreased under conditions of obesity, insulin resistance and type 2 diabetes. Administration of adiponectin causes glucose-lowering effects and ameliorates insulin resistance in mice. Conversely, adiponectin-deficient mice exhibit insulin resistance and diabetes. This insulin-sensitizing effect of adiponectin seems to be mediated by an increase in fatty-acid oxidation through activation of AMP kinase and PPAR-alpha. Here we report the cloning of complementary DNAs encoding adiponectin receptors 1 and 2 (AdipoR1 and AdipoR2) by expression cloning. AdipoR1 is abundantly expressed in skeletal muscle, whereas AdipoR2 is predominantly expressed in the liver. These two adiponectin receptors are predicted to contain seven transmembrane domains, but to be structurally and functionally distinct from G-protein-coupled receptors. Expression of AdipoR1/R2 or suppression of AdipoR1/R2 expression by small-interfering RNA supports our conclusion that they serve as receptors for globular and full-length adiponectin, and that they mediate increased AMP kinase and PPAR-alpha ligand activities, as well as fatty-acid oxidation and glucose uptake by adiponectin.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This translocation results from stimulating p38 MAPK via either AMPK [10,44] or interaction with APPL1 [55].”
From Adiponectin and Its Mimics on Skeletal Muscle: Insulin Sensitizers, Fat Burners, Exercise Mimickers, Muscling Pills … or Everything Together? (2020) · cites this paper as [10]
In the citing paper
“Third, ApN induces the translocation of GLUT4 to the plasma membrane, thereby promoting glucose uptake [10,54].”
From Adiponectin and Its Mimics on Skeletal Muscle: Insulin Sensitizers, Fat Burners, Exercise Mimickers, Muscling Pills … or Everything Together? (2020) · cites this paper as [10]
Citations
Cites
A simple method for displaying the hydropathic character of a protein
Kyte, J., & Doolittle, R. F. (1982) · Journal of Molecular Biology · doi:10.1016/0022-2836(82)90515-0 · Cited by 22,927
Initial sequencing and comparative analysis of the mouse genome
Mouse Genome Sequencing Consortium (2002) · Nature · doi:10.1038/nature01262 · Cited by 7,187
Efficient selection for high-expression transfectants with a novel eukaryotic vector
Niwa, H., Yamamura, K., & Miyazaki, J. (1991) · Gene · doi:10.1016/0378-1119(91)90434-d · Cited by 5,149
Yamauchi, T., Kamon, J., Waki, H., Terauchi, Y., Kubota, N., Hara, K., Mori, Y., Ide, T., Murakami, K., Tsuboyama-Kasaoka, N., et al. (2001) · Nature Medicine · doi:10.1038/90984 · Cited by 4,915
Yamauchi, T., Kamon, J., Minokoshi, Y., Ito, Y., Waki, H., Uchida, S., Yamashita, S., Noda, M., Kita, S., Ueki, K., et al. (2002) · Nature Medicine · doi:10.1038/nm788 · Cited by 4,238
Self-citationA Novel Serum Protein Similar to C1q, Produced Exclusively in Adipocytes
Scherer, P. E., Williams, S. P., Fogliano, M., Baldini, G., & Lodish, H. F. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.45.26746 · Cited by 3,238
The adipocyte-secreted protein Acrp30 enhances hepatic insulin action
Berg, A. H., Combs, T. P., Du, X., Brownlee, M., & Scherer, P. E. (2001) · Nature Medicine · doi:10.1038/90992 · Cited by 2,526
AdipoQ Is a Novel Adipose-specific Gene Dysregulated in Obesity
Hu, E., Liang, P., & Spiegelman, B. M. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.18.10697 · Cited by 2,261
Diet-induced insulin resistance in mice lacking adiponectin/ACRP30
Maeda, N., Shimomura, I., Kishida, K., Nishizawa, H., Matsuda, M., Nagaretani, H., Furuyama, N., Kondo, H., Takahashi, M., Arita, Y., et al. (2002) · Nature Medicine · doi:10.1038/nm724 · Cited by 2,114
Maeda, K., Okubo, K., Shimomura, I., Funahashi, T., Matsuzawa, Y., & Matsubara, K. (1996) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1996.0587 · Cited by 2,081
Flagged first, then by citations
Cited by
Sorted by citations
Items 501–600 of 1,021
Waki, H., Nakamura, M., Yamauchi, T., Wakabayashi, K.-I., Yu, J., Hirose, L., Take, K., Sun, W., Iwabu, M., Okada‐Iwabu, M., et al. (2011) · PLoS Genetics · doi:10.1371/journal.pgen.1002311 · Cited by 129
Adiponectin: a link between obesity and cancer
Barb, D., Pazaitou‐Panayiotou, K., & Mantzoros, C. S. (2006) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.15.8.917 · Cited by 125
Staiger, H., Kaltenbach, S., Staiger, K., Stefan, N., Fritsche, A., Guirguis, A., Péterfi, C., Weisser, M., Machicao, F. E., Stümvoll, M., et al. (2004) · Diabetes · doi:10.2337/diabetes.53.9.2195 · Cited by 122
Adiponectin Induces Pro-inflammatory Programs in Human Macrophages and CD4+ T Cells
Cheng, X., Folco, E. J. E., Shimizu, K., & Libby, P. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.409516 · Cited by 122
Exercise in the Metabolic Syndrome
Golbidi, S., Mesdaghinia, A., & Laher, I. (2012) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2012/349710 · Cited by 127
Tacke, F., Wüstefeld, T., Horn, R., Luedde, T., Rao, A. S., Manns, M. P., Trautwein, C., & Brabant, G. E. (2005) · Journal of Hepatology · doi:10.1016/j.jhep.2004.12.024 · Cited by 122
Adiponectin mediates an antiproliferative response in human MDA-MB 231 breast cancer cells
Giudicelli (1994) · Oncology Reports · doi:10.3892/or_00000098 · Cited by 122
Adiponectin Promotes Monocyte-to-Fibroblast Transition in Renal Fibrosis
Yang, J., Lin, S.-C., Chen, G., He, L., Hu, Z., Chan, L., Trial, J., Entman, M. L., & Wang, Y. (2013) · Journal of the American Society of Nephrology · doi:10.1681/asn.2013030217 · Cited by 123
Adiponectin: A Promising Target for the Treatment of Diabetes and Its Complications
Begum, M., Choubey, M., Tirumalasetty, M. B., Arbee, S., Mohib, M. M., Wahiduzzaman, M., Mamun, M. A., Uddin, M. B., & Mohiuddin, M. S. (2023) · Life · doi:10.3390/life13112213 · Cited by 138
“The molecular structure of both forms of the receptor exhibits signi fi cant homology, featuring an internal N-terminus and an external C-terminus [28].”
BackgroundGonzález‐Sánchez, J. L., Zabena, C. A., Martínez‐Larrad, M. T., Fernández, C., Pérez‐Barba, M., Laakso, M., & Serrano‐Ríos, M. (2005) · Obesity Research · doi:10.1038/oby.2005.91 · Cited by 121
Adipokine Gene Expression in Brain and Pituitary Gland
Wilkinson, M., Brown, R., Imran, S. A., & Ur, E. (2007) · Neuroendocrinology · doi:10.1159/000108635 · Cited by 120
Drug-induced fatty liver disease: An overview of pathogenesis and management
Satapathy, S. K., Kuwajima, V. K., Nadelson, J., Atiq, O., & Sanyal, A. J. (2015) · Annals of Hepatology · doi:10.5604/16652681.1171749 · Cited by 122
Angiotensin-(1-7), Adipokines and Inflammation
Lelis, D. D. F., de Freitas, D. F., Machado, A. S., Crespo, T. S., & Santos, S. H. S. (2019) · Metabolism · doi:10.1016/j.metabol.2019.03.006 · Cited by 124
Detection of adiponectin in cerebrospinal fluid in humans
Neumeier, M., Weigert, J., Buettner, R., Wanninger, J., Schäffler, A., Müller, A. M., Killian, S., Sauerbruch, S., Schlachetzki, F., Steinbrecher, A., et al. (2007) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00119.2007 · Cited by 120
Hopf, T. A., Morinaga, S., Ihara, S., Touhara, K., Marks, D. S., & Benton, R. (2015) · Nature Communications · doi:10.1038/ncomms7077 · Cited by 118
Adiponectin Inhibits Lipolysis in Mouse Adipocytes
Qiao, L., Kinney, B., Schaack, J. B., & Shao, J. (2011) · Diabetes · doi:10.2337/db10-1017 · Cited by 117
Hypoadiponectinemia—Cause or Consequence of Human “Insulin Resistance”?
Cook, J. R., & Semple, R. K. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2286 · Cited by 119
Adiponectin association with T‐cadherin protects against neointima proliferation and atherosclerosis
Fujishima, Y., Maeda, N., Matsuda, K., Masuda, S., Mori, T., Fukuda, S., Sekimoto, R., Yamaoka, M., Obata, Y., Kita, S., et al. (2017) · The FASEB Journal · doi:10.1096/fj.201601064r · Cited by 119
“T-cadherin protein is extremely low in liver tissue and hepatocytes (23), but AdipoR1/R2 are present in liver, although plasma adiponectin level was not changed in mice lacking AdipoR1/R2 (54).”
BackgroundInfluentialTomita, K., Oike, Y., Teratani, T., Taguchi, T., Noguchi, M., Suzuki, T., Mizutani, A., Yokoyama, H., Irie, R., Sumimoto, H., et al. (2008) · Hepatology · doi:10.1002/hep.22365 · Cited by 121
A High‐Fat Diet Has a Tissue‐Specific Effect on Adiponectin and Related Enzyme Expression
Barnea, M., Shamay, A., Stark, A. H., & Madar, Z. (2006) · Obesity · doi:10.1038/oby.2006.251 · Cited by 118
Signaling mechanisms underlying the insulin-sensitizing effects of adiponectin
Cheng, K. K. Y., Lam, K. S. L., Wang, B., & Xu, A. (2013) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2013.06.006 · Cited by 119
Adipose Tissue: Physiology to Metabolic Dysfunction
Richard, A. J., White, U. A., Elks, C. M., & Stephens, J. M. (2020) · Europe PMC (PubMed Central) · Cited by 118
Signalling mechanisms underlying the metabolic and other effects of adipokines on the heart
Karmazyn, M., Purdham, D. M., Rajapurohitam, V., & Zeidan, A. (2008) · Cardiovascular Research · doi:10.1093/cvr/cvn115 · Cited by 118
PALANIVEL, R., FANG, X., PARK, M., EGUCHI, M., PALLAN, S., DEGIROLAMO, S., LIU, Y., WANG, Y., XU, A., & SWEENEY, G. (2007) · Cardiovascular Research · doi:10.1016/j.cardiores.2007.04.011 · Cited by 117
Cytokines in alcoholic liver disease
An, L., Wang, X., & Cederbaum, A. I. (2012) · Archives of Toxicology · doi:10.1007/s00204-012-0814-6 · Cited by 116
Miyazaki, T., Bub, J. D., Uzuki, M., & Iwamoto, Y. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.05.076 · Cited by 118
Adiponectin, obesity, and cardiovascular disease
Faßhauer, M., Paschke, R., & Stümvoll, M. (2004) · Biochimie · doi:10.1016/j.biochi.2004.09.016 · Cited by 120
Effects of resistance versus endurance training on serum adiponectin and insulin resistance index.
Ahmadizad, S., Haghighi, A. H., & Hamedinia, M. R. (2007) · European Journal of Endocrinology · doi:10.1530/eje-07-0223 · Cited by 115
Adiponectin is a negative regulator of antigen‐activated T cells
Wilk, S., Scheibenbogen, C., Bauer, S., Jenke, A., Rother, M., Guerreiro, M., Kudernatsch, R., Goerner, N., Poller, W. C., Elligsen‐Merkel, D., et al. (2011) · European Journal of Immunology · doi:10.1002/eji.201041349 · Cited by 114
An APPL1-AMPK signaling axis mediates beneficial metabolic effects of adiponectin in the heart
Fang, X., Palanivel, R., Cresser, J., Schram, K., Ganguly, R., Thong, F. S. L., Tuinei, J., Xu, A., Abel, E. D., & Sweeney, G. (2010) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00086.2010 · Cited by 119
Crabb, D. W., & Liangpunsakul, S. (2006) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2006.04582.x · Cited by 116
Gray, B. R., Steyn, F. J., Davies, P. S. W., & Vitetta, L. (2013) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2013.197 · Cited by 118
The effect of PPARγ ligands on the adipose tissue in insulin resistance
Hammarstedt, A., Andersson, C. X., Sopasakis, V. R., & Smith, U. (2005) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2005.04.008 · Cited by 119
Adiponectin: Probe of the molecular paradigm associating diabetes and obesity
Ghoshal, K. (2015) · World Journal of Diabetes · doi:10.4239/wjd.v6.i1.151 · Cited by 125
Genomics of metabolic adaptations in the peripartal cow
Loor, J. J. (2010) · animal · doi:10.1017/s1751731110000960 · Cited by 115
Zhang, D., Wang, X., Wang, B., Garza, J., Fang, X., Wang, J., Scherer, P. E., Brenner, R., Zhang, W., & Lu, X.-Y. (2016) · Molecular Psychiatry · doi:10.1038/mp.2016.58 · Cited by 115
Dietary Flavonoids in the Prevention of T2D: An Overview
Alkhalidy, H., Wang, Y., & Liu, D. (2018) · Nutrients · doi:10.3390/nu10040438 · Cited by 123
“Adiponectin binds to its receptors adiponectin receptor protein 1(AdipoR1) and adiponectin receptor protein 2 (AdipoR2), which are expressed in the liver and skeletal muscle [152] and mediate its various biological effects, including activation of peroxisome proliferator-activated receptor (PPAR)-α [153] and AMPK [154…”
BackgroundHuang, J., Yen, C., Chiang, H.-W., Hung, K., Tsai, T., & Wu, K. (2004) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2004.02.017 · Cited by 113
Takeuchi, T., Adachi, Y., Ohtsuki, Y., & Furihata, M. (2007) · Medical Molecular Morphology · doi:10.1007/s00795-007-0364-9 · Cited by 118
Diehl, A. M. (2004) · Clinics in Liver Disease · doi:10.1016/j.cld.2004.04.012 · Cited by 117
Fujioka, D., Kawabata, K.-I., Saito, Y., Kobayashi, T., Nakamura, T., Kodama, Y., Takano, H., Obata, J.-E., Kitta, Y., Umetani, K., et al. (2006) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00987.2005 · Cited by 115
The role of adiponectin in reproduction: from polycystic ovary syndrome to assisted reproduction
Michalakis, K. G., & Segars, J. H. (2010) · Fertility and Sterility · doi:10.1016/j.fertnstert.2010.05.010 · Cited by 114
Shared pathways for neuroprogression and somatoprogression in neuropsychiatric disorders
Morris, G., Puri, B. K., Walker, A. J., Maes, M. H. J., Carvalho, A. F., Bortolasci, C. C., Walder, K. R., & Berk, M. (2019) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2019.09.025 · Cited by 119
Caballero, A. E. (2004) · Current Diabetes Reports · doi:10.1007/s11892-004-0074-9 · Cited by 114
Adiponectin: linking the fat cell to insulin sensitivity
Goldfine, A. B., & Kahn, C. R. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14727-7 · Cited by 116
van Stijn, C. M. W., Kim, J., Lusis, A. J., Barish, G. D., & Tangirala, R. K. (2014) · The FASEB Journal · doi:10.1096/fj.14-253831 · Cited by 116
Adiponectin: A Key Adipokine in Alcoholic Fatty Liver
You, M., & Rogers, C. Q. (2009) · Experimental Biology and Medicine · doi:10.3181/0902-mr-61 · Cited by 113
Adipose tissue in health and disease
Harvey, I. C., Boudreau, A., & Stephens, J. M. (2020) · Open Biology · doi:10.1098/rsob.200291 · Cited by 126
Antiatherosclerotic and Anti-Insulin Resistance Effects of Adiponectin: Basic and Clinical Studies
Han, S. H., Sakuma, I., Shin, E. K., & Koh, K. K. (2009) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2009.06.004 · Cited by 115
Adaptive failure to high-fat diet characterizes steatohepatitis in Alms1 mutant mice
Arsov, T., Larter, C. Z., Nolan, C. J., Petrovsky, N., Goodnow, C. C., Teoh, N., Yeh, M. M., & Farrell, G. C. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.02.032 · Cited by 118
Liu, Y., Michael, M. D., Kash, S. F., Bensch, W. R., Monia, B. P., Murray, S. F., Otto, K. A., Syed, S. K., Bhanot, S., Sloop, K. W., et al. (2006) · Endocrinology · doi:10.1210/en.2006-0708 · Cited by 113
Adiponectin: an adipokine with protective features against metabolic syndrome.
Esfahani, M., Movahedian, A., Baranchi, M., & Goodarzi, M. T. (2015) · Europe PMC (PubMed Central) · Cited by 111
Adiponectin, a unique adipocyte-derived factor beyond hormones
Maeda, N., Funahashi, T., Matsuzawa, Y., & Shimomura, I. (2019) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2019.10.021 · Cited by 113
Inflammation and Oxidative Stress in Obesity-Related Glomerulopathy
Tang, J., Yan, H., & Zhuang, S. (2012) · International Journal of Nephrology · doi:10.1155/2012/608397 · Cited by 115
Punyadeera, C., Zorenc, A. H. G., Koopman, R., McAinch, A. J., Smit, E., MANDERS, R. J. F., KEIZER, H. A., Cameron‐Smith, D., & van Loon, L. J. C. (2005) · European Journal of Endocrinology · doi:10.1530/eje.1.01872 · Cited by 111
The Role of Ceramides in Diabetes and Cardiovascular Disease Regulation of Ceramides by Adipokines
Field, B. C., Gordillo, R., & Scherer, P. E. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.569250 · Cited by 110
“Ceramidase Activity of Adiponectin Receptors After the discovery of adiponectin, the most common adiponectin receptors, AdipoR1 and AdipoR2, were cloned (129).”
BackgroundKrietsch, T., Fernandes, M. S., Kero, J. T., Lösel, R., Heyens, M., Lam, E. W. ‐., Huhtaniemi, I. T., Brosens, J. J., & Gellersen, B. (2006) · Molecular Endocrinology · doi:10.1210/me.2006-0129 · Cited by 111
Kashyap, S. R., Diab, D. L., Baker, A. R., Yerian, L. M., BAJAJ, H. S., Gray‐McGuire, C., Schauer, P. R., Gupta, M. K., Feldstein, A. E., Hazen, S. L., et al. (2009) · Obesity · doi:10.1038/oby.2009.89 · Cited by 111
Mechanisms of obesity-induced metabolic and vascular dysfunctions
Caldwell, R. W. (2019) · Frontiers in bioscience · doi:10.2741/4758 · Cited by 112
“Adiponectin enhances insulin sensitivity by increasing glucose and fatty acid metabolism through the activation of AMP Kinase (AMPK) and PPAR alpha (138-140).”
AICAR stimulates adiponectin and inhibits cytokines in adipose tissue
Lihn, A. S., Jessen, N., Pedersen, S. B., Lund, S. A., & Richelsen, B. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.02.139 · Cited by 111
The role of the adipocyte hormone adiponectin in cardiovascular disease
Hug, C., & Lodish, H. F. (2005) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2005.01.001 · Cited by 113
Alterations in plasma and tissue lipids associated with obesity and metabolic syndrome
Aguilera, C. M., Gil‐Campos, M., Cañete, R., & Gil, Á. (2008) · Clinical Science · doi:10.1042/cs20070115 · Cited by 112
Role of adiponectin system in insulin resistance
Caselli, C. (2014) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2014.09.003 · Cited by 111
A guide and guard: The many faces of T-cadherin
Philippova, M., Joshi, M. B., Kyriakakis, E., Pfaff, D., Erné, P., & Resink, T. J. (2009) · Cellular Signalling · doi:10.1016/j.cellsig.2009.01.035 · Cited by 109
Hsu, C., Liu, C., Liu, C., Wang, C., Chen, C., Lai, M., Chen, P., Kao, J., & Chen, D. (2007) · Liver International · doi:10.1111/j.1478-3231.2007.01626.x · Cited by 109
Mechanisms regulating energy metabolism by adiponectin in obesity and diabetes
Fang, X., & Sweeney, G. (2006) · Biochemical Society Transactions · doi:10.1042/bst0340798 · Cited by 110
Obesity and asthma: beyond TH2 inflammation
Leiria, L. O., Martins, M. A., & Saad, M. J. A. (2014) · Metabolism · doi:10.1016/j.metabol.2014.10.002 · Cited by 111
Adiponectin, Adiposity, and Insulin Resistance in Children and Adolescents
Punthakee, Z., DELVIN, E. E., O’Loughlin, J. L., Paradis, G., Levy, E. H., Platt, R. W., & Lambert, M. A. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-2346 · Cited by 109
Maternal Overweight Programs Insulin and Adiponectin Signaling in the Offspring
Shankar, K., Kang, P., Harrell, A., Zhong, Y., Marecki, J. C., Ronis, M. J. J., & Badger, T. M. (2010) · Endocrinology · doi:10.1210/en.2010-0017 · Cited by 107
Adiponectin action in skeletal muscle
Liu, Y., & Sweeney, G. (2013) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2013.08.003 · Cited by 111
Adiponectin and its association with insulin resistance and type 2 diabetes
Sheng, T., & Yang, K. (2008) · Journal of genetics and genomics/Journal of Genetics and Genomics · doi:10.1016/s1673-8527(08)60047-8 · Cited by 122
Duda, M. K., O’Shea, K. M., LEI, B., Barrows, B. R., Azimzadeh, A., McElfresh, T. A., Hoit, B. D., Kop, W. J., & Stanley, W. C. (2007) · Cardiovascular Research · doi:10.1016/j.cardiores.2007.07.002 · Cited by 105
Nogues, P., Santos, E. D., Jammes, H., Berveiller, P., Arnould, L., Vialard, F., & Dieudonné, M. (2019) · Clinical Epigenetics · doi:10.1186/s13148-019-0612-6 · Cited by 114
“Lastly, we showed that in human placenta, ADIPOR2 is 10- to 100-fold less expressed than ADIPOR1, as generally described in other tissues and cell types [52, 53].”
BackgroundKim, Y., & Park, C. W. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20071782 · Cited by 113
“AdipoR1 and AdipoR2 have seven transmembrane domains and are significantly homologous, sharing 67 % amino acid identity [27], whereas T-cadherin is considered to be an adiponectin-binding protein but its functional significance has not been completely determined.”
BackgroundRole of adipokines in the control of energy metabolism: focus on adiponectin
Lafontan, M., & Viguerie, N. (2006) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2006.08.002 · Cited by 118
Wang, Y., Lau, W. B., Gao, E., Tao, L., Yuan, Y., Li, R., Wang, X., Koch, W. J., & Ma, X. (2009) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00663.2009 · Cited by 108
O'Leary, V. B., Jorett, A. E., Marchetti, C. M., Gonzalez, F., Phillips, S. A., Ciaraldi, T. P., & Kirwan, J. P. (2007) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00123.2007 · Cited by 107
Aghamohammadzadeh, R., Withers, S., Lynch, F. M., Greenstein, A. S., Malik, R. A., & Heagerty, A. M. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01479.x · Cited by 107
Role of adiponectin in metabolic and cardiovascular disease
Lee, S., & Kwak, H. (2014) · Journal of Exercise Rehabilitation · doi:10.12965/jer.140100 · Cited by 105
Wu, P., Wen, W., Li, J., Xu, J., Zhao, M., Chen, H., & Sun, J. M. (2019) · Hormone and Metabolic Research · doi:10.1055/a-0958-2441 · Cited by 111
“The another adipocytokine, adiponectin, is also an adipose-derived secretory protein, and plays a pivotal role in insulin signal and energy metabolism as well [10].”
BackgroundBlüher, M., Williams, C. J., Klöting, N., Hsi, A., Ruschke, K., Oberbach, A., Faßhauer, M., Berndt, J., Schön, M. R., Wolk, A., et al. (2007) · Diabetes Care · doi:10.2337/dc07-1257 · Cited by 107
Park, S., Choi, J. H., Ryu, H. S., Pak, Y. K., Park, K. S., Lee, H. K., & Lee, W. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.005611 · Cited by 107
Plasma Adiponectin and Endogenous Glucose Production in Humans
Stefan, N., Stümvoll, M., de Courten, B. V., Weyer, C., Funahashi, T., Matsuzawa, Y., Bogardus, C., & Tataranni, P. A. (2003) · Diabetes Care · doi:10.2337/diacare.26.12.3315 · Cited by 107
Adipose tissue, inflammation and endothelial dysfunction.
Chudek, J. T., & Więcek, A. (2006) · PubMed · Cited by 105
Tsuduki, T., Kikuchi, I., Kimura, T., Nakagawa, K., & Miyazawa, T. (2013) · Food Chemistry · doi:10.1016/j.foodchem.2013.02.025 · Cited by 106
Placental Function and the Development of Fetal Overgrowth and Fetal Growth Restriction
Dumolt, J. H., Powell, T. L., & Jansson, T. (2021) · Obstetrics and Gynecology Clinics of North America · doi:10.1016/j.ogc.2021.02.001 · Cited by 111
Shinmura, K., Tamaki, K., & Bolli, R. (2005) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2005.03.010 · Cited by 104
Contribution of adipocyte-derived factors to beta-cell dysfunction in diabetes
Zhao, Y.-F., Feng, D. D., & Chen, C. (2005) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2005.11.008 · Cited by 110
Christiansen, T., Paulsen, S. K., Bruun, J. M., Ploug, T., Pedersen, S. B., & Richelsen, B. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-2505 · Cited by 108
Wang, Y., Wang, X., Lau, W. B., Yuan, Y., Booth, D., Li, J.-J., Scalia, R., Preston, K., Gao, E., Koch, W., et al. (2014) · Circulation Research · doi:10.1161/circresaha.114.302439 · Cited by 104
Akimoto, M., Maruyama, R., Kawabata, Y., Tajima, Y., & Takenaga, K. (2018) · Cell Death & Disease · doi:10.1038/s41419-018-0851-z · Cited by 104
Metabolic Inflammation in Inflammatory Bowel Disease
Gonçalves, P., Magro, F., & Martel, F. (2014) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000209 · Cited by 107
Matsuda, K., Fujishima, Y., Maeda, N., Mori, T., Hirata, A., Sekimoto, R., Tsushima, Y., Masuda, S., Yamaoka, M., Inoue, K., et al. (2014) · Endocrinology · doi:10.1210/en.2014-1618 · Cited by 104
Growth hormone is a positive regulator of adiponectin receptor 2 in 3T3‐L1 adipocytes
Faßhauer, M., Klein, J. C., Kralisch, S., Klier, M., Lössner, U., Blüher, M., & Paschke, R. (2004) · FEBS Letters · doi:10.1016/s0014-5793(03)01525-4 · Cited by 104
Maternal-fetal cross-talk via the placenta: influence on offspring development and metabolism
Kramer, A. C., Jansson, T., Bale, T. L., & Powell, T. L. (2023) · Development · doi:10.1242/dev.202088 · Cited by 119
Molecular mechanisms of signal transduction via adiponectin and adiponectin receptors
Heiker, J. T., Kosel, D., & Beck‐Sickinger, A. G. (2010) · Biological Chemistry · doi:10.1515/bc.2010.104 · Cited by 105
Kusunoki, J., Kanatani, A., & Moller, D. E. (2006) · Endocrine · doi:10.1385/endo:29:1:91 · Cited by 104
The Role of Adiponectin in Endothelial Dysfunction and Hypertension
Rojas, E., Rodríguez-Molina, D., Bolli, P., Israili, Z. H., Faría, J., Fidilio, E., Bermúdez, V., & Velasco, M. (2014) · Current Hypertension Reports · doi:10.1007/s11906-014-0463-7 · Cited by 104
Effect of vitamin K2 on type 2 diabetes mellitus: A review
Li, Y., Chen, J. P., Duan, L., & Li, S. (2017) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2017.11.020 · Cited by 106
“[32] Yamauchi T, Kamon J, Yusuke I, Atsushi T, Takehiko Y, Shunhun K, et al.”
BackgroundWu, X., Luo, J., Liu, H., Cui, W., Guo, K., Zhao, L., Bai, H., Guo, W., Guo, H., Feng, D., et al. (2020) · Translational Stroke Research · doi:10.1007/s12975-019-00768-x · Cited by 104
“Adiponectin (APN) is the main adipokine regulating glucose and lipid metabolism [13, 14].”
Background
Metadata
- Authors
- Yamauchi, T., Kamon, J., Ito, Y., Tsuchida, A., Yokomizo, T., Kita, S., Sugiyama, T., Miyagishi, M., Hara, K., Tsunoda, M., Murakami, K., Ohteki, T., Uchida, S., Takekawa, S., Waki, H., Tsuno, N. H., Shibata, Y., Terauchi, Y., Froguel, P., Tobe, K., Koyasu, S., Taira, K., Kitamura, T., Shimizu, T., Nagai, R., & Kadowaki, T.
- Affiliations
- The University of Tokyo (JP)
- Nissan Chemical Corporation (Japan) (JP)
- Japan Science and Technology Agency (JP)
- National Institute of Advanced Industrial Science and Technology (JP)
- Keio University (JP)
- Centre National de la Recherche Scientifique (FR)
- Institute of Medical Science, The University of Tokyo (JP)
- Corresponding author
- Kadowaki, Takashi
- ORCID
- Venue
- Nature
- Published
- 2003-06-12
- Volume
- 423
- Issue
- 6941
- Pages
- 762-769
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1997978122
- Cited by
- 3,176
- References
- 28
- Citations by year
- 2026: 43 · 2025: 50 · 2024: 77 · 2023: 102 · 2022: 89 · 2021: 136 · 2020: 114 · 2019: 120 · 2018: 114 · 2017: 117 · 2016: 117 · 2015: 154 · 2014: 173 · 2013: 190 · 2012: 170
- FWCI
- 115.85
- Type
- journal article
- Language
- en
- Update notices
- erratum (2004-10-28)
- Open access
- closed
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- Novartis Foundation
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Health Sciences › Medicine › Physiology (medical) › Adipose Tissue and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Peroxisome Proliferator-Activated Receptors
- Keywords
- adiponectin, adiponectin receptors, AdipoR1, AdipoR2, insulin resistance, type 2 diabetes, AMP kinase, PPARα, fatty acid oxidation, glucose uptake, skeletal muscle, liver, adipokines, obesity, receptor cloning
- MeSH terms
- Amino Acid Sequence, Animals, Cell Line, Cloning, Molecular, Diabetes Mellitus, Endothelium, Vascular, Fatty Acids, Glucose, Humans, Hypoglycemic Agents, Ligands, Molecular Sequence Data, Oxidation-Reduction, Proteins, Receptors, Cell Surface, Transcription Factors, Receptors, Cytoplasmic and Nuclear, Hepatocytes, Muscle Cells, RNA Interference, RNA, Small Interfering, Intercellular Signaling Peptides and Proteins, Mice, Adiponectin, Receptors, Adiponectin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review